Retour
4
Également cotée sous
SHPMY
OTC
Fourchette du Jour
1,46 €
1,46 €
Fourchette 52 Semaines
1,46 €
15,70 €
Volume
100
Moyenne 50J / 200J
1,49 €
/
1,53 €
Clôture Précédente
1,46 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 1,9 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | 6,5 | 3,7 |
| Net Margin % | 1,7 | 3,8 |
| Rev Growth 5Y % | 9,4 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
1,50 €
1,43 € – 1,59 €
|
320 B | 1 |
| FY2026 |
1,36 €
1,30 € – 1,45 €
|
300 B | 1 |
Points Clés
Revenue grew 9,44% annually over 5 years — modest growth
Earnings grew 20,82% over the past year
Generating 3,43B in free cash flow
P/E of 1,86 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,69%
Capital efficient — spends only 0,87% of revenue on capex
Croissance
Revenue Growth (5Y)
9,44%
Revenue (1Y)5,75%
Earnings (1Y)20,82%
FCF Growth (3Y)29,02%
Qualité
Return on Equity
6,49%
ROIC5,11%
Net Margin1,65%
Op. Margin2,96%
Sécurité
Debt / Equity
0,67
Current Ratio1,36
Interest Coverage5,01
Valorisation
P/E Ratio
1,86
P/B Ratio0,12
EV/EBITDA2,52
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,75% | Revenue Growth (3Y) | 8,93% |
| Earnings Growth (1Y) | 20,82% | Earnings Growth (3Y) | -9,97% |
| Revenue Growth (5Y) | 9,44% | Earnings Growth (5Y) | 0,31% |
| Profitability | |||
| Revenue (TTM) | 275,25B | Net Income (TTM) | 4,55B |
| ROE | 6,49% | ROA | 2,06% |
| Gross Margin | 11,13% | Operating Margin | 2,96% |
| Net Margin | 1,65% | Free Cash Flow (TTM) | 3,43B |
| ROIC | 5,11% | FCF Growth (3Y) | 29,02% |
| Safety | |||
| Debt / Equity | 0,67 | Current Ratio | 1,36 |
| Interest Coverage | 5,01 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 1,86 | P/B Ratio | 0,12 |
| P/S Ratio | 0,03 | PEG Ratio | 4,73 |
| EV/EBITDA | 2,52 | Dividend Yield | 0,01% |
| Market Cap | 8,46B | Enterprise Value | 20,51B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 275,25B | 260,30B | 231,98B | 215,82B | 191,91B |
| Net Income | 4,55B | 3,77B | 5,62B | 5,09B | 4,50B |
| EPS (Diluted) | 1,23 | 1,02 | 1,61 | 1,79 | 1,58 |
| Gross Profit | 30,63B | 31,33B | 30,49B | 28,54B | 27,44B |
| Operating Income | 8,14B | 7,67B | 9,01B | 8,21B | 7,18B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 221,21B | 211,97B | 198,13B | 163,44B | 149,19B |
| Total Liabilities | 137,47B | 131,65B | 120,13B | 104,37B | 94,44B |
| Shareholders' Equity | 71,68B | 68,52B | 67,06B | 49,36B | 45,35B |
| Total Debt | 47,79B | 42,90B | 38,56B | 31,69B | 31,79B |
| Cash & Equivalents | 35,74B | 30,52B | 27,40B | 22,39B | 22,30B |
| Current Assets | 171,82B | 162,43B | 149,51B | 116,49B | 107,56B |
| Current Liabilities | 126,04B | 122,37B | 110,69B | 91,82B | 88,13B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#607 of 618
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026